Pay in 4 interest-free payments of $6.81 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
All products are sold for research, laboratory, or analytical purposes only and are not for human consumption
Researched applications In the published preclinical and clinical literature the effects of AOD-9604 are documented in the following areas: Obesity , Phase 2b failure (2007), but a complementary mechanism in combination protocols Lipolysis in animal models , robustly demonstrated (Heffernan 2001, Ng 2009) Inhibition of lipogenesis , demonstrated in hepatocytes and adipocytes Osteoarthritis and cartilage regeneration , emerging Phase 1/2 data (mLuna Pharmaceuticals 2018+) Tendinopathy , preclinical models Age-related sarcopenia (cachexia) , exploratory plans Lipodystrophy , preclinical data in animal models Hyperlipidemia , secondary endpoints in Phase 2 trials Science & studies 4.1 Key publications Heffernan M., Summers R.J., Thorburn A., et al
Those With Metabolic Syndrome Risk Factors Elevated triglycerides, impaired fasting glucose, high blood pressure, and increased waist circumference are the defining features of metabolic syndrome
Chromium: An essential mineral that plays a key role in carbohydrate and fat metabolism
Our physicians will assess your skin, discuss your goals, and design a White Booster+ program tailored to your needs
Redox regulation of RNA binding after exposure to nitric oxide
